UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 3, 2014

ORGENESIS INC.
(Exact name of registrant as specified in its charter)

Nevada 000-54329 980583166
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

21 Sparrow Circle, White Plains, NY 10605
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: +972.4.824.2051

N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))


2

Item 1.01          Entry into a Material Definitive Agreement.

On April 3, 2014, we entered into a consulting agreement with Aspen Agency Limited, a Hong Kong corporation, pursuant to which Aspen has agreed to provide investment banking, investor relations and business development services to our company. In consideration for Aspen’s services, we have agreed to issue to Aspen 3,000,000 stock options to acquire shares of our common stock at an exercise price of $0.52 per share, for a period of three years. The options will be subject to vesting provisions.

The term of the consulting agreement is from April 3, 2014 and will run for an indefinite period unless terminated by either party providing 30 days written notice.

For a complete description of all of the terms and conditions of the agreement please refer to the form of consulting agreement which is filed as exhibit 10.1 to this current report on Form 8-K.

We granted the securities to one non-U.S. persons (as that term is defined in Regulation S of the Securities Act of 1933, as amended ) relying on Section 4(2) of the Securities Act of 1933, as amended and/or Rule 506 promulgated pursuant to the Securities Act of 1933, as amended .

Item 3.02         Unregistered Sales of Equity Securities.

The information required by this item is included under Item 1.01 of this Current Report on Form 8-K.

Item 9.01.        Financial Statements and Exhibits.

(d)                    Exhibits

10.1

Consulting Agreement dated April 3, 2014 with Aspen Agency Limited

   
10.2

Stock Option Agreement dated April 3, 2014 with Aspen Agency Limited

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ORGENESIS INC.

By:
/s/ Vered Caplan
Vered Caplan
Interim President, Chief Executive Officer and
Chairperson of the board of directors

April 7, 2014



AGREEMENT

This Agreement (the “Agreement”) is made and entered into effective as of April 3, 2014 (the ”Effective Date”), between Orgenesis, Inc., a Nevada corporation, with its principal offices located at 21 Sparrow Circle, White Plains, NY 10605, United States of America (the “COMPANY”) and Aspen Agency Limited, a Hong Kong corporation, with a principal address at Unit 1010, 10/F Miramar Tower, 132 Nathan Road, Tsimshatsui, Kowloon, Kong Kong S.A.R. (the ”CONSULTANT”).

WHEREAS, the Company is seeking to expand its business through contracts with distributors and various other strategic business relationships in Asia; and

WHEREAS, the Company is seeking to increase market awareness of the Company in European markets; and

WHERAS, the Company is seeking to engage Consultant to assist it in Investment Banking, Investor Relations, Business Development, and aligning strategic alliances for the purposes of introducing the Company to the European market; and

WHEREAS, Consultant wishes to assist the Company by finding strategic business relationships; and

WHEREAS, Consultant has relationships which it can leverage to assist the Company in strategic business development for its product in the Asian markets; and

WHEREAS, the Company wishes to retain Consultant to provide such services for the consideration as set forth herein.

NOW, THEREFORE, the parties agree as follows:

1.              Appointment as Consultant

Appointment . On the basis of the representations, warranties and covenants contained in this Agreement, but subject to the terms and conditions herein set forth, the Company is appointing Consultant for the purpose of utilizing the Consultant’s extensive contacts to structure and consummate strategic business relationships in the European markets, in addition, to utilizing its expertise and the expertise of its employees to bring awareness to the Company’s publicly traded common stock in European markets, for a period of one year from the date of this Agreement (the “Term”). The Term shall be automatically extended by both parties should the Consultant be engaged in an ongoing negotiation with any targeted party as instructed by the Company until the completion of such negotiation, or as otherwise mutually agreed upon by the parties hereto. Consultant accepts the appointment, agrees on the terms and conditions herein set forth and agrees to use its best efforts during the Term to perform the services described herein.

1.2            Scope of Appointment . Consultant, by virtue of this Agreement or otherwise, is not an agent of the Company. As a Consultant for the Company under this Agreement, Consultant is to:



1.2.1

contact prospective offerees of the Company’s products and services;

   
1.2.2

give such offerees information concerning the Company, its business and personnel as prescribed by the Company;

   
1.2.3

introduce such prospective offerees to the Company which offerees who reside outside the United States and Canada invest in private placements of the Company;

   
1.2.4

assist the Company in negotiations with prospective offerees;

   
1.2.5

assist the Company in potential investment banking transactions in Europe; and

   
1.2.6

introduce Orgenesis to the Asian markets.

               1.3       Nature of Relationship .

               1.3.1 Independent Contractor Status . Consultant shall be an independent contractor and, except as expressly provided or authorized in this Agreement, shall have no authority to act for or represent the Company.

               1.3.2 Use of Other Consultants/Exclusivity . The Company shall be free to use other Consultants for the offering of its products and services. However, Consultant shall not, during the Term, provide services to any company which offers products or services similar to those offered by the Company.

               1.3.3 No Additional Compensation . Consultant shall not be entitled to any compensation from or reimbursement of expenses by, the Company in connection with the performance of Consultant’s duties hereunder, except as set forth herein.

2.             Representations and Warranties of the Company .

The Company represents, warrants and agrees with Consultant that:

               2.1 The Company is duly organized and validly existing corporation under the laws of the State of Nevada, and has all requisite authority to own its property and conduct its business as currently conducted.

               2.2 The execution and delivery by the Company of this Agreement and the Option, and the performance by the Company of its obligations hereunder, have been duly and validly authorized by the Company. This Agreement has been duly and validly executed and delivered by the Company and constitutes legal, valid and binding obligations of the Company enforceable against the Company in accordance with its terms.


3.              Representations, Warranties and Covenants of the Consultant .

Consultant represents, warrants and agrees with the Company that Consultant has full power and authority to execute and deliver, to perform its obligations under, and to consummate the transactions contemplated by this Agreement. This Agreement is a valid and legally binding obligation of Consultant, enforceable against it in accordance with its terms. Consultant is not restricted or prohibited, contractually, by court order, agreement or otherwise, from entering into and performing this Agreement, and the services to be performed hereunder, and Consultant’s execution and performance of this Agreement is not a violation or breach of any agreement between Consultant and any other person or entity.

Consultant will not trade in the securities of Company while in possession of undisclosed material information regarding the Company, and will keep all Company confidential information completely confidential and not disclose to any party without Company’s written consent.

Consultant will comply with all applicable securities and other laws, rules and regulations in carrying out its obligations under this agreement.

4.             Compensation .

As compensation for the successful completion of the Consultant’s services as described herein, as determined by the Company acting reasonably or as otherwise set out in this Agreement, the Company shall grant to the Consultant the option to purchase up to 3,000,000 shares of the Company’s common stock (“Option”) exercisable at $0.52 per share for a period of 3 years from the date of this agreement (“Exercise Period”). After expiration of the Exercise Period Consultant shall have no right to purchase the shares of common stock underlying the Option.

5.              Grant of Option .

5.1            Grant of Option . Subject to the terms and conditions of this Agreement, upon the execution of this Agreement, the Company will grant to the Consultant the Option to purchase up to 3,000,000 shares of common stock (the “Option Shares”) as listed in clause 4 upon the terms and conditions of this Agreement. The Option will vest and be exercisable as follows:

                a) 1,000,000 Options (the “First Tranche”) will vest as at the date of execution of this Agreement;

                b) in the event the Consultant exercises all 1,000,000 vested First Tranche Options during the first 12 months of this Agreement, the “Second Tranche” of 2,000,000 Option tranches will vest.

Any Options that are not vested and will not vest as the conditions listed above have not been fulfilled will terminate immediately, and the Consultant will have no further rights with respect to the Options.

5.2            Exercise Price . The price to be paid by the Consultant for each Option Share in the event of an exercise of all or any portion of the Option shall be $0.52 (the “Exercise Price”) per Option Share.


5.3            Duration of Option . The Option for the First Tranche of 1,000,000 Options shall vest and become immediately exercisable, the Second Tranche shall vest after full exercise of the First Tranche (provided the First Tranche is exercised in full during the first 12 months of this Agreement), and all Options shall expire on and no longer be exercisable three years from the date of this Agreement.

5.4           Exercise of Option .

5.4.1         Manner . The Option may be exercised by the Consultant in whole or in part, subject to the conditions contained herein, by the Consultant (i) paying in full the total Exercise Price for the shares purchased and (ii) delivering, in person or by registered mail, written notice of exercise to the Company substantially in the form of the Option Exercise Form attached hereto as Exhibit A. As soon as practicable after such notice and payment are received, the Company shall cause the Consultant to be recorded on the books of the Company as the owner of the Option Shares purchased, and the Company shall deliver to the Purchaser one or more duly issued stock certificates evidencing such ownership.

5.4.2         Payment . At the time of exercise of this Option, the Consultant shall pay the Exercise Price of the Option Shares by certified bank check or wire transfer in immediately available funds made payable to the Company.

5.4.3         Shares Restricted . The Consultant acknowledges that the Shares upon exercise of the Options will be restricted securities under U.S. securities laws and will bear a legend under Rule 144 promulgated under the Securities Act of 1933 as advised by legal counsel to the Company. In the event that the Company files a new registration statement after the execution of this Agreement for the registration under the Securities Act of 1933 of other securities, the Company will use reasonable efforts to include the Option Shares in the same registration statement to register the Option Shares. The Company may determine in its discretion or on the advice of a financial advisor that the addition of the Option Shares would be detrimental to the Company’s interests, and in such case it may defer the registration of the Option Shares to another registration statement.

6.              Governing Law; Jurisdiction . This Agreement and the enforcement thereof shall be governed by and construed under the laws of the State of Nevada. The parties hereto consent to the non-exclusive jurisdiction of any state or federal court and any appellate court from any appeal thereof in any action or proceeding arising out of or relating to this Agreement, or the transactions contemplated hereby.

7.             Termination . Consultant or the Company shall have the right to terminate this Agreement by giving written notice to the other; provided, however, that Consultant shall have 30 days to exercise any vested Options after termination. The Company will not terminate this Agreement without a reasonable basis for doing so.

8.              Notices . All notices provided for by this Agreement shall be made in writing either (i) by actual delivery of the notice, or (ii) by the mailing of the notice in the United States mail to the party's last known address, by certified or registered mail, return receipt requested. The notice shall be deemed to be received in case (i) on the date of its actual receipt by the party entitled to notice and in case (ii) on the date of deposit in the United States mail.


9.              Severability . If any portion of this Agreement is held invalid or inoperative, then, so far as is reasonable and possible (i) the remainder of this Agreement shall be considered valid and operative and (ii) effect shall be given to the intent manifested by the portion held invalid or inoperative.

10.            Counterparts . This Agreement may be executed in a number of identical counterparts, each of which shall be deemed to be an original, but all of which constitute, collectively, one and the same Agreement; but in making proof of this Agreement, it shall not be necessary to produce or account for more than one counterpart.

11.           Modification or Amendment . This Agreement may not be modified or amended except by written agreement executed by the parties to this Agreement.

12.           Captions . The captions used in this Agreement are for convenience only and shall not be construed in interpreting this Agreement.

13.           Parties . This Agreement shall be binding upon and inure solely to the benefit of the parties to this Agreement, the controlling persons of the parties and their respective successors, legal representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of by virtue of this Agreement or any provision contained in this Agreement.

14.           Entire Agreement . This Agreement contains the entire understanding between the parties and supersedes any prior understanding or written or oral agreements between them respecting the subject matter of this Agreement.

15.           Arbitration . In the event that there shall be a dispute, controversy or claim arising out of, relating to or in connection with this Agreement or related to the subject matter hereof, the Parties agrees that such dispute shall be submitted to binding arbitration in New York City, under the auspices of, and pursuant to the rules of, the American Arbitration Association as then in effect, or such other procedures as the Parties may agree to at the time, before a tribunal of three arbitrators, one of which shall be selected by each of the Parties to the dispute and the third of which shall be selected by the two arbitrators so selected. Any award issued as a result of such arbitration shall be final and binding between the Parties, and shall be enforceable by any court having jurisdiction over the Party against whom enforcement is sought.

16.           Indemnification .

               a. Indemnification of Company by Consultant. Consultant agrees to indemnify and hold harmless the Company and its officers, directors, employees and agents, up to the amount of compensation received under this Agreement, against any and all loss, liability, claims, damage and expense, including reasonable attorney fees, arising out of or based upon Finder’s breach of this Agreement.


               b. Indemnification of Consultant by Company. The Company agrees to indemnify and hold harmless Consultant, against any and all loss, liability, claims, damage and expense, including reasonable attorney fees, arising out of or based on this Agreement, including, but not limited to (1) a breach of this Agreement by the Company or (2) any claims arising out of Consultant’s performance of services under this Agreement, provided such performance was lawful, in compliance with the Company’s instructions and made in good faith.

IN WITNESS WHEREOF, the undersigned have executed this Agreement on the date set opposite their respective signatures below, but effective as provided herein.

Orgenesis, Inc.   Aspen Agency Limited
     
By: /s/ Vered Caplan   By: /s/ Charles van Musscher
         
Name: Vered Caplan   Name: Charles van Musscher
         
Title: CEO   Title: Director
         
Date: April 3, 2014   Date: April 3, 2014


EXHIBIT A
OPTION EXERCISE FORM

            This Option Exercise Form (this “Agreement”) by and between the undersigned optionee, Aspen Agency Limited, a Hong Kong registered corporation (the “Optionee”), and the undersigned optionor, Orgenesis, Inc. (the “Company”), is executed and delivered pursuant to the Consulting Agreement (“Agreement”) dated April 3, 2014 by and between the Optionee and the Company.

            Subject to the foregoing, the Optionee hereby purchases _________________shares (the “Option Shares”) of common stock of the Company pursuant to that certain option (the “Option”) granted to the Optionee under the Agreement. Such shares are purchased at a per share exercise price of $0.52 per share (“Exercise Price”).

            Concurrently upon the delivery of this Agreement to the Company, the Optionee is delivering the Exercise Price multiplied by the number of shares purchased by Optionee to the Company in accordance with and in the manner set forth in the Agreement. Upon receipt of this notice and payment, the Company hereby agrees to immediately (i) cause the Optionee to be recorded on the books of the Company as the owner of the Option Shares purchased, and (ii) deliver to the Optionee one or more duly issued stock certificates evidencing such ownership.

            Dated: [__________________]

  Aspen Agency Limited,
  Optionee
   
  By: _____________________________________________
   
   
   
  Receipt Acknowledged By:
   
  Orgenesis, Inc.
   
   
  By: _____________________________________________



THE SECURITIES REPRESENTED HEREBY HAVE BEEN OFFERED IN AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S. PERSON (AS DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”).

NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933 ACT.

STOCK OPTION AGREEMENT
(Non U.S. Persons)

This AGREEMENT is entered into as of the 3rd day of April, 2014 (the “Date of Grant”).

BETWEEN:

ORGENESIS INC. , a company incorporated pursuant to the laws of the State of Nevada, with an office at 21 Sparrow Circle, White Plains, NY 10605

(the “Company”)

AND:

ASPEN AGENCY LIMITED , a company incorporated pursuant to the laws of Hong Kong with an address at Unit 1010, 10/F Miramar Tower, 132 Nathan Road Tsimshatsui, Kowloon, Kong Kong S.A.R.

(the “Optionee”)

WHEREAS: The Company wishes to grant stock options to purchase a total of 3,000,000 Optioned Shares (as defined herein) to the Optionee.

NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.

DEFINITIONS

     
1.1

In this Agreement, the following terms shall have the following meanings:

     
(a)

Common Stock ” means the shares of common stock of the Company;

     
(b)

Exercise Price ” means $0.52 per share;



2

  (c)

Expiry Date ” means three years following the Date of Grant;

     
  (d)

Notice of Exercise ” means a notice in writing addressed to the Company at its address first recited hereto (or such other address of which the Company may from time to time notify the Optionee in writing), substantially in the form attached as Schedule “A” hereto, which notice shall specify therein the number of Optioned Shares in respect of which the Options are being exercised;

     
  (e)

Options ” means the irrevocable right and option to purchase, from time to time, all, or any part of the Optioned Shares granted to the Optionee by the Company pursuant to Section 2.1 of this Agreement;

     
  (f)

Optioned Shares ” means the shares of Common Stock that are issued pursuant to the exercise of the Options;

     
  (g)

Securities ” means, collectively, the Options and the Optioned Shares;

     
  (h)

Shareholders ” means holders of record of the shares of Common Stock;

     
  (i)

U.S. Person ” shall have the meaning ascribed thereto in Regulation S under the 1933 Act, and for the purpose of the Agreement includes any person in the United States; and

     
  (j)

Vested Options ” means the Options that have vested in accordance with Section 2.2 of this Agreement.


2.

THE OPTIONS

     
2.1

The Company hereby grants to the Optionee, on the terms and conditions set out in this Agreement, Options to purchase a total of 3,000,000 Optioned Shares at the Exercise Price.

     
2.2

The Options are subject to the following vesting provisions:

     
(a)

1,000,000 Options (the “First Tranche”) will vest as at the date of execution of this Agreement;

     
(b)

in the event the Optionee exercises all 1,000,000 vested First Tranche Options during the first 12 months of this Agreement, the “Second Tranche” of 2,000,000 Option tranches will vest. If the First Tranche is not exercised in the first 12 months of this Agreement, the Second Tranche options will expire immediately and be of no further effect.


The Options may be exercised immediately after vesting.

   
2.3

The Options shall, at 5:00 p.m. (Pacific time) on the Expiry Date, expire and be of no further force or effect whatsoever.

   
2.4

The Company shall not be obligated to cause the issuance, transfer or delivery of a certificate or certificates representing Optioned Shares to the Optionee, until provision has been made by the Optionee, to the satisfaction of the Company, for the payment of the aggregate Exercise Price for all Optioned Shares for which the Options shall have been exercised, and for satisfaction of any tax withholding obligations associated with such exercise.



3

2.5

The Optionee shall have no rights whatsoever as a shareholder in respect of any of the Optioned Shares (including any right to receive dividends or other distribution therefrom or thereon) except in respect of which the Options have been properly exercised in accordance with the terms of this Agreement.

     
2.6

Subject to the provisions of this Agreement and subject to compliance with any applicable securities laws, the Options shall be exercisable, in full or in part, at any time after vesting, until termination; provided, however, that if the Optionee is subject to the reporting and liability provisions of Section 16 of the Securities Exchange Act of 1934 , as amended with respect to the Common Stock, the Optionee shall be precluded from selling, transferring or otherwise disposing of any Common Stock underlying any of the Options during the six months immediately following the grant of the Options. If less than all of the shares included in the vested portion of any Options are purchased, the remainder may be purchased at any subsequent time prior to the Expiry Date. Only whole shares may be issued pursuant to the exercise of any Options, and to the extent that any Option covers less than one share, it is not exercisable.

     
2.7

Each exercise of the Options shall be by means of delivery of a Notice of Exercise (which may be in the form attached hereto as Schedule “A”) to the President of the Company at its principal executive office, specifying the number of Optioned Shares to be purchased and accompanied by payment in cash by certified check or cashier’s check in the amount of the full Exercise Price for the Common Stock to be purchased. In addition to payment in cash by certified check or cashier’s check and if agreed to in advance by the Company, an Optionee or transferee of the Options may pay for all or any portion of the aggregate Exercise Price by complying with one or more of the following alternatives:

     
(a)

by delivering a properly executed Notice of Exercise together with irrevocable instructions to a broker promptly to sell or margin a sufficient portion of the Common Stock and deliver directly to the Company the amount of sale or margin loan proceeds to pay the Exercise Price; or

     
(b)

by complying with any other payment mechanism approved by the Board at the time of exercise.

     
2.8

It is a condition precedent to the issuance of Optioned Shares that the Optionee execute and/or deliver to the Company all documents and withholding taxes required in accordance with applicable laws.

     
2.9

Nothing in this Agreement shall obligate the Optionee to purchase any Optioned Shares except those Optioned Shares in respect of which the Optionee shall have exercised the Options in the manner provided in this Agreement.

     
2.10

Appropriate and proportional adjustments in the exercise price of the Options and in the number of Options granted or to be granted may be made by the Board of Directors in its discretion to give effect to adjustments in the number of common shares of the Company resulting from subdivisions, consolidations or reclassification of the common shares of the Company, the payment of stock dividends by the Company or other relevant changes in the capital of the Company.



4

2.11

By accepting the Options, the Optionee represents and agrees that none of the Optioned Shares purchased upon exercise of the Options will be distributed in violation of applicable federal and state laws and regulations. The Optionee further represents and agrees to provide the Company with any other document reasonably requested by the Company or the Company’s Counsel.

     
2.12

The Options are not transferable or assignable.

     
2.13

The Options are not subject to a stock option plan, but the Company in its discretion may determine that the Options are subject to the Company’s stock option plan, and if so, the terms of the Company’s stock option plan will govern in the event of any conflict between this Agreement and the stock option plan.

     
3.

TERMINATION OF OPTIONS

     
3.1

Termination of Employment and Vested Options. The Optionee or the Company shall have the right to terminate their contractual relationship by giving written notice to the other; provided, however, that Optionee shall have 30 days to exercise any vested Options after termination. The Company will not terminate this Agreement without a reasonable basis for doing so. Vested Options shall terminate, to the extent not previously exercised, upon the occurrence of the first of the following events:

     
(a)

Expiration. Three years from the Date of Grant.

     
(b)

Termination for Cause. The date of the first discovery by the Company of any reason for the termination of an Optionee’s contractual relationship with the Company or any related company for cause (as reasonably determined by the Company), and, if an Optionee’s employment is suspended pending any investigation by the Company as to whether the Optionee’s consulting should be terminated for cause, the Optionee’s rights under this Agreement shall likewise be suspended during the period of any such investigation, in each of the above events provided a notice was delivered to the Optionee and the breach was not cured within seven days following its delivery.


3.2

Termination of Employment and Unvested Options. Unvested Options shall terminate immediately upon termination of the Optionee’s contractual relationship with the Company for any reason whatsoever.

   
4.

DOCUMENTS REQUIRED FROM OPTIONEE

   
4.1

The Optionee must complete, sign and return an executed copy of this Agreement to the Company.

   
4.2

The Optionee shall complete, sign and return to the Company as soon as possible, on request by the Company, any documents, questionnaires, notices and undertakings as may be required by regulatory authorities, and applicable law.



5

5.

ACKNOWLEDGEMENTS OF THE OPTIONEE

The Optionee acknowledges and agrees that:

  (a)

none of the Options or the Optioned Shares have been registered under the 1933 Act or under any state securities or “blue sky” laws of any state of the United States, and, unless so registered, may not be offered or sold in the United States or, directly or indirectly, to U.S. Persons, except in accordance with the provisions of Regulation S, pursuant to an effective registration statement under the 1933 Act, or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the 1933 Act and in each case only in accordance with applicable state securities laws;

     
  (b)

the Company has not undertaken, and will have no obligation, to register any of the Securities under the 1933 Act;

     
  (c)

the Optionee has received and carefully read this Agreement and the public information which has been filed with the Securities and Exchange Commission (the “SEC”) in compliance or intended compliance with applicable securities legislation (collectively, the “Company Information”);

     
  (d)

the decision to execute this Agreement and acquire the Securities hereunder has not been based upon any oral or written representation as to fact or otherwise made by or on behalf of the Company, and such decision is based entirely upon a review of the Company Information (the receipt of which is hereby acknowledged);

     
  (e)

no securities commission or similar regulatory authority has reviewed or passed on the merits of the Securities;

     
  (f)

there is no government or other insurance covering the Securities;

     
  (g)

there are risks associated with an investment in the Securities;

     
  (h)

the Optionee and the Optionee’s advisor(s) (if applicable) have had a reasonable opportunity to ask questions of and receive answers from the Company in connection with the distribution of the Securities hereunder, and to obtain additional information, to the extent possessed or obtainable without unreasonable effort or expense, necessary to verify the accuracy of the information about the Company;

     
  (i)

the books and records of the Company were available upon reasonable notice for inspection, subject to certain confidentiality restrictions, by the Optionee during reasonable business hours at its principal place of business, and all documents, records and books in connection with the distribution of the Securities hereunder have been made available for inspection by the Optionee, the Optionee’s attorney and/or advisor(s) (if applicable);

     
  (j)

the Company is entitled to rely on the representations and warranties and the statements and answers of the Optionee contained in this Agreement;



6

  (k)

the Optionee will indemnify and hold harmless the Company and, where applicable, its directors, officers, employees, agents, advisors and shareholders, from and against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all fees, costs and expenses whatsoever reasonably incurred in investigating, preparing or defending against any claim, lawsuit, administrative proceeding or investigation whether commenced or threatened) arising out of or based upon any representation or warranty of the Optionee contained herein or in any document furnished by the Optionee to the Company in connection herewith being untrue in any material respect or any breach or failure by the Optionee to comply with any covenant or agreement made by the Optionee to the Company in connection therewith;

       
  (l)

none of the Securities are listed on any stock exchange or automated dealer quotation system and no representation has been made to the Optionee that any of the Securities will become listed on any stock exchange or automated dealer quotation system; except that currently certain market makers make market in the Common Stock on the OTC Bulletin Board;

       
  (m)

the Company will refuse to register any transfer of the Securities not made in accordance with the provisions of Regulation S, pursuant to an effective registration statement under the 1933 Act or pursuant to an available exemption from the registration requirements of the 1933 Act and in accordance with applicable state and provincial securities laws;

       
  (n)

the statutory and regulatory basis for the exemption claimed for the offer of the Securities, although in technical compliance with Regulation S, would not be available if the offering is part of a plan or scheme to evade the registration provisions of the 1933 Act or any applicable state and provincial securities laws;

       
  (o)

the Optionee has been advised to consult the Optionee’s own legal, tax and other advisors with respect to the merits and risks of an investment in the Securities and with respect to applicable resale restrictions, and it is solely responsible (and the Company is not in any way responsible) for compliance with:

       
  (i)

any applicable laws of the jurisdiction in which the Optionee is resident in connection with the distribution of the Securities hereunder, and

       
  (ii)

applicable resale restrictions; and

       
  (p)

this Agreement is not enforceable by the Optionee unless it has been accepted by the Company.


6.

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE OPTIONEE

The Optionee hereby represents and warrants to and covenants with the Company (which representations, warranties and covenants shall survive the closing) that:

  (a)

the Optionee has the legal capacity and competence to enter into and execute this Agreement and to take all actions required pursuant hereto;



7

  (b)

the Optionee has duly executed and delivered this Agreement and it constitutes a valid and binding agreement of the Optionee enforceable against the Optionee in accordance with its terms;

     
  (c)

the Optionee is not acquiring the Securities for the account or benefit of, directly or indirectly, any U.S. Person;

     
  (d)

the Optionee is not a U.S. Person;

     
  (e)

the Optionee is resident in the jurisdiction set out on page 1 of this Agreement;

     
  (f)

the Optionee has not acquired the Securities as a result of, and will not itself engage in, any “directed selling efforts” (as defined in Regulation S under the 1933 Act) in the United States in respect of the Securities which would include any activities undertaken for the purpose of, or that could reasonably be expected to have the effect of, conditioning the market in the United States for the resale of the Securities; provided, however, that the Optionee may sell or otherwise dispose of the Securities pursuant to registration thereof under the 1933 Act and any applicable state and provincial securities laws or under an exemption from such registration requirements;

     
  (g)

the Optionee is outside the United States when receiving and executing this Agreement and is acquiring the Securities as principal for the Optionee’s own account, for investment purposes only, and not with a view to, or for, resale, distribution or fractionalisation thereof, in whole or in part, and, in particular, it has no intention to distribute either directly or indirectly any of the Securities in the United States or to U.S. Persons, and no other person has a direct or indirect beneficial interest in such Securities;

     
  (h)

the Optionee is not an underwriter of, or dealer in, the Common Stock, nor is the Optionee participating, pursuant to a contractual agreement or otherwise, in the distribution of the Securities;

     
  (i)

the Optionee (i) has adequate net worth and means of providing for his/her/its current financial needs and possible personal contingencies, (ii) has no need for liquidity in this investment, and (iii) is able to bear the economic risks of an investment in the Securities for an indefinite period of time, and can afford the complete loss of such investment;

     
  (j)

the Optionee is aware that an investment in the Company is speculative and involves certain risks, including the possible loss of the investment, and the Optionee has carefully read and considered the matters set forth under the caption “Risk Factors” appearing in the Company’s various disclosure documents, filed with the SEC;

     
  (k)

the Optionee has the requisite knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of the investment in the Securities and the Company;

     
  (l)

the Optionee understands and agrees that the Company and others will rely upon the truth and accuracy of the acknowledgements, representations and agreements contained in this Agreement, and agrees that if any of such acknowledgements, representations and agreements are no longer accurate or have been breached, the Optionee shall promptly notify the Company;



8

  (m)

the Optionee has made an independent examination and investigation of an investment in the Securities and the Company and has depended on the advice of its legal and financial advisors and agrees that the Company will not be responsible in anyway whatsoever for the Optionee’s decision to invest in the Securities and the Company;

       
  (n)

the Optionee is not aware of any advertisement of any of the Securities and is not acquiring the Securities as a result of any form of general solicitation or general advertising including advertisements, articles, notices or other communications published in any newspaper, magazine or similar media or broadcast over radio or television, or any seminar or meeting whose attendees have been invited by general solicitation or general advertising;

       
  (o)

no person has made to the Optionee any written or oral representations:

       
  (i)

that any person will resell or repurchase any of the Securities;

       
  (ii)

that any person will refund the purchase price of any of the Securities; or

       
  (iii)

as to the future price or value of any of the Securities; and

       
  (p)

if the Optionee is a consultant of the Company, the Optionee has entered into a written consulting agreement with the Company or a related entity of the Company and spends or will spend a significant amount of time and attention on the affairs and business of the Company or such related entity.


7.

ACKNOWLEDGEMENT

The Optionee has acknowledged that the decision to purchase the Securities was solely made on the basis of publicly available information contained in the Company Information.

8.

LEGENDING OF SUBJECT SECURITIES

   
8.1

The Optionee hereby consents to the placement of a legend on any certificate or the Optionee consents to the placement of a legend on any certificate or other document evidencing any of the Optioned Shares to the effect that such Optioned Shares have not been registered under the 1933 Act, any state securities or “blue sky” laws, or under the prospectus and registration requirements of any applicable Canadian securities laws, and setting forth or referring to the restrictions on transferability and sale thereof contained in this Agreement, such legend to be substantially as follows:



9

 
THESE SECURITIES WERE ISSUED IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE 1933 ACT) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). ACCORDINGLY, NONE OF THE SECURITIES TO WHICH THIS CERTIFICATE RELATES HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD IN THE UNITED STATES OR, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE 1933 ACT.
 

8.2

The Optionee hereby agrees to the Company making a notation on its records or giving instructions to the registrar and transfer agent of the Company in order to implement the restrictions on transfer set forth and described in this Agreement.

   
9.

GENERAL RESALE RESTRICTIONS

   
9.1

The Optionee acknowledges that any resale of any of the Optioned Shares will be subject to resale restrictions contained in the securities legislation applicable to the Optionee or proposed transferee. The Optionee acknowledges that none of the Optioned Shares have been registered under the 1933 Act or the securities laws of any state of the United States. The Optioned Shares may not be offered or sold in the United States unless registered in accordance with federal securities laws and all applicable state securities laws or exemptions from such registration requirements are available.

   
9.2

The Optionee acknowledges and agrees that the Optionee is solely responsible (and the Company is not in any way responsible) for compliance with applicable resale restrictions.

   
10.

NO EMPLOYMENT RELATIONSHIP

The grant of an Option shall in no way constitute any form of agreement or understanding binding on the Company or any related company, express or implied, that the Company or any related company will employ or contract with an Optionee, for any length of time, nor shall it interfere in any way with the Company’s or, where applicable, a related company’s right to terminate Optionee’s employment at any time, which right is hereby reserved.

11.

GOVERNING LAW

This Agreement is governed by the laws of the State of Nevada.

12.

COSTS

The Optionee acknowledges and agrees that all costs and expenses incurred by the Optionee (including any fees and disbursements of any special counsel retained by the Optionee) relating to the acquisition of the Securities shall be borne by the Optionee.


10

13.

SURVIVAL

This Agreement, including without limitation the representations, warranties and covenants contained herein, shall survive and continue in full force and effect and be binding upon the parties hereto notwithstanding the completion of the purchase of the shares underlying the Options by the Optionee pursuant hereto.

14.

ASSIGNMENT

This Agreement is not transferable or assignable.

15.

CURRENCY

Unless explicitly stated otherwise, all funds in this Agreement are stated in United States dollars.

16.

SEVERABILITY

The invalidity or unenforceability of any particular provision of this Agreement shall not affect or limit the validity or enforceability of the remaining provisions of this Agreement.

17.

COUNTERPARTS AND ELECTRONIC MEANS

This Agreement may be executed in several counterparts, each of which will be deemed to be an original and all of which will together constitute one and the same instrument. Delivery of an executed copy of this Agreement by electronic facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution and delivery of this Agreement as of the date first above written.

18.

ENTIRE AGREEMENT

This Agreement is the only agreement between the Optionee and the Company with respect to the Options, and this Agreement, supersede all prior and contemporaneous oral and written statements and representations and contain the entire agreement between the parties with respect to the Options.

IN WITNESS WHEREOF the parties hereto have duly executed this Agreement as of the date first above written.

ORGENESIS INC.

 

Per:     ________________________________________
            Authorized Signatory

 

ASPEN AGENCY LIMITED

 

Per:     ________________________________________
            Authorized Signatory


SCHEDULE “A”
NOTICE OF EXERCISE

TO: Orgenesis Inc.
  21 Sparrow Circle, White Plains, NY 10605

This Notice of Exercise shall constitute a proper Notice of Exercise pursuant to Section 2.7 of the Stock Option Agreement dated as of ____________________ (the “Agreement”), between Orgenesis Inc. (the “Company”) and the undersigned. The undersigned hereby elects to exercise Optionee’s option to purchase ____________________ shares of the common stock of the Company at a price of US $0.52 per share, for aggregate consideration of US $____________, on the terms and conditions set forth in the Agreement. Such aggregate consideration, in the form specified in Section 2.7 of the Agreement, accompanies this notice.

The Optionee represents and warrants to the Company that all representations and warranties set out in the Agreement are true as of the date of the exercise of the Options under the Agreement.

Please deliver a share certificate in respect of the Optioned Shares referred to in the Stock Option and Subscription Agreement surrendered herewith but not presently subscribed for, to the Optionee.

The Optionee hereby directs the Company to issue, register and deliver the certificates representing the shares as follows:

Registration Information:   Delivery Instructions:
     
     
Name to appear on certificates   Name
     
     
Address   Address
     
     
City, State, and Zip Code    
     
     
    Telephone Number

DATED at _____________________________, the _______ day of______________, _______.

  X
  Signature
   
   
  (Name and, if applicable, Office)
   
   
  (Address)
   
   
  (City, State, and Zip Code)
   
   
  Fax Number or E-mail Address
   
   
  SIN, SSN or Other Tax Identification Number